http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019243329-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1893e58a79a78de604ff4b09e05c578b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-64 |
| filingDate | 2019-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70e08abcc9bd35e12ebc5a10e5f1129b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cf4656319b557dc1a71693b06e91dec http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_930e5d818f2c31bcdef3f5b747bb6c61 |
| publicationDate | 2019-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2019243329-A1 |
| titleOfInvention | PEPTIDE LIGANDS FOR BINDING TO INTEGRIN ανβ3 |
| abstract | A peptide ligand specific for integrin ανβ3 comprising a polypeptide comprising three residues selected from cysteine, L-2,3 -diaminopropionic acid (Dap), N-beta-alkyl-L-2,3- diaminopropionic acid (N-AlkDap) and N-beta-haloalkyl-L-2,3-diaminopropionic acid (N- HAlkDap), with the proviso that at least one of said three residues is selected from Dap, N- AlkDap or N-HAlkDap, the said three residues being separated by at least two loop sequences, and a molecular scaffold, the peptide being linked to the scaffold by covalent alkylamino linkages with the Dap or N-AlkDap or N-HAlkDap residues of the polypeptide and by thioether linkages with the cysteine residues of the polypeptide when the said three residues include cysteine, such that two polypeptide loops are formed on the molecular scaffold. Also provided are drug conjugates comprising the peptide ligands conjugated to one or more effector groups and pharmaceutical compositions comprising the conjugates. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020148527-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020148528-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023056388-A1 |
| priorityDate | 2018-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 322.